Development and validation of a clinical risk score nomogram for predicting voriconazole trough concentration above 5 mg/L: a retrospective cohort study-Reference-Cited by-同舟云学术

Development and validation of a clinical risk score nomogram for predicting voriconazole trough concentration above 5 mg/L: a retrospective cohort study

Published:2024-07-08 Issue: Volume: Page:1-9
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Xie Mengyuan¹²,Jiang Manxue¹²,Xu Jian¹²,Zhu Yulin¹²,Kong Lingti¹²³^ORCID

Affiliation:

1. Department of Pharmacy, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China

2. School of Pharmacy, Bengbu Medical University, Bengbu, China

3. Institute of Emergency and Critical Care Medicine, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China

Funder

Anhui Province key clinical specialty construction project

Natural Science Foundation of Bengbu Medical University

Research Innovation Program for College Graduates of Bengbu Medical College

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/1120009X.2024.2376453

Reference44 articles.

1. Editorial: Synergistic therapy for invasive fungal infection

2. Evaluation of Pharmacokinetics and Safety With Bioequivalence of Voriconazole Injection of 2 Formulations in Chinese Healthy Volunteers: Bioequivalence Study

3. Impact of Inflammation on Intra-individual Variation in Trough Voriconazole Concentration in Patients with Hematological Malignancies

4. Population Pharmacokinetics of Voriconazole and Optimization of Dosage Regimens Based on Monte Carlo Simulation in Patients With Liver Cirrhosis

5. External evaluation of population pharmacokinetic models for voriconazole in Chinese adult patients with hematological malignancy